DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2240793/astrazeneca-azn-to-acquire-amolyt-pharma-for-1-05-billion?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2240793 Mar 14, 2024 - AstraZeneca (AZN) enters into an agreement to acquire Amolyt Pharma to strengthen its rare disease pipeline by adding the latter's late-stage hypoparathyroidism treatment candidate, eneboparatide. 0

https://www.zacks.com/stock/news/2240074/3d-systems-ddd-metal-3d-printers-gain-adoption-at-wilting?cid=CS-ZC-FT-analyst_blog|company_news_tech_sector-2240074 Mar 13, 2024 - 3D Systems' (DDD) products, two single laser DMP Flex 350 and one DMP Flex 350 Dual metal 3D printer, get added to Wilting's manufacturing floor. 0

https://www.fool.com/investing/2024/03/13/cathie-wood-goes-bargain-hunting-3-stocks-she-just/?source=iedfolrf0000001 Mar 13, 2024 - The popular growth-stock investor added to these three existing positions on Tuesday. 0

https://www.zacks.com/commentary/2239630/are-these-high-growth-high-dividend-yielding-stocks-on-your-radar?cid=CS-ZC-FT-investment_ideas-2239630 Mar 12, 2024 - Among the Zacks Rank #1 (Strong Buy) list, several companies are standing out in terms of their growth and high dividend yields, adding more value to their stocks. 0

https://www.zacks.com/stock/news/2239193/novo-nordisk-nvo-is-considered-a-good-investment-by-brokers-is-that-true?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2239193 Mar 12, 2024 - Based on the average brokerage recommendation (ABR), Novo Nordisk (NVO) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying? 0

https://www.zacks.com/stock/news/2239197/is-li-auto-inc-sponsored-adr-li-a-buy-as-wall-street-analysts-look-optimistic?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2239197 Mar 12, 2024 - Based on the average brokerage recommendation (ABR), Li Auto Inc. Sponsored ADR (LI) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying? 0

https://www.zacks.com/stock/news/2239200/wall-street-analysts-think-lam-research-lrcx-is-a-good-investment-is-it?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2239200 Mar 12, 2024 - Based on the average brokerage recommendation (ABR), Lam Research (LRCX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying? 0

https://www.denverpost.com/2024/03/11/colorado-economy-job-growth-revisions-hiring-strong/ Mar 11, 2024 - Colorado's economy did much better than first estimated when it came to adding jobs last year and hiring is off to a strong start in 2024, according to an update Monday from the Colorado Department of Labor and Employment. 0

https://www.zacks.com/stock/news/2238710/here-s-why-you-should-avoid-kennametal-kmt-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2238710 Mar 11, 2024 - Lower volume in aerospace and defense end markets, and increasing costs are weighing on Kennametal (KMT). Unfavorable foreign currency movement is an added concern. 0

https://www.wired.com/story/sam-altman-is-reinstated-to-openais-board/ Mar 08, 2024 - OpenAI named Sam Altman, its fired-then-rehired CEO, to its board of directors Friday. It also added three women with executive experience at Sony, Meta, and the Bill & Melinda Gates Foundation. 0